Review of Lithium and Electroconvulsive Therapy Effects on Disease Modification in Various Studies
A systematic review found that lithium and electroconvulsive therapy provided the most substantial evidence as interventions that may modify disease progression. However, it does not present original data.
- Tags
- #MSResearch
- Most relevant to
- —
- Human efficacy
- Not established from this source
- Mechanism
- Not reported
- Evidence strength
- Not graded
- Outcome
- Not reported
Why it matters
This review highlights potential therapeutic avenues for disease modification, emphasizing the need for future studies to focus on outcomes reflecting disease progression rather than just symptom relief.
What this does not prove
The review does not provide original research data and emphasizes the need for future trials to change focus for meaningful results.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Systematic review
- Participants / samples
- Not reported
- Randomised
- Not reported
- Controlled
- Not reported
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- 2026-10-26
- Evidence reviewed
- Abstract only
- Regulatory approval
- Not reported
- Research areas
- Not classified
- Biological target
- Not reported
- Pathway
- Not reported
- Population
- Not reported
- Size of effect
- Not reported
- Secondary endpoints
- Not reported
- MRI endpoints
- Not reported
- Biomarkers
- Not reported
- Safety
- Not reported
Original sources
- Primary evidenceDisease-modifying interventions in psychiatry. ↗DOI: 10.1177/00048674261493034
Supporting passages (5)
publication datePublication date: 2026-10-26
study designPublication types: Journal Article
findingsLithium and electroconvulsive therapy showed the greatest evidence as disease-modifying interventions.
limitationsHowever, to establish this and identify potential other disease-modifying treatments, there needs to be a shift in the focus of psychiatric clinical trials to include primary outcomes that reflect disease progression and not just acute symptom burden.
peer reviewedPublication types: Journal Article
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.